Acorda Therapeutics - Stock Price History | ACOR

Historical daily share price chart and data for Acorda Therapeutics since 2020 adjusted for splits. The latest closing stock price for Acorda Therapeutics as of March 31, 2020 is 0.93.
  • The all-time high Acorda Therapeutics stock closing price was 44.50 on January 26, 2015.
  • The Acorda Therapeutics 52-week high stock price is 13.39, which is 1339.8% above the current share price.
  • The Acorda Therapeutics 52-week low stock price is 0.70, which is 24.7% below the current share price.
  • The average Acorda Therapeutics stock price for the last 52 weeks is 4.56.
Acorda Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 7.8785 16.2200 17.4700 1.5200 2.0400 -86.91%
2018 23.5966 22.6500 32.6000 12.9400 15.5800 -27.37%
2017 21.5250 19.5000 30.1500 13.8000 21.4500 14.10%
2016 26.5247 42.2500 42.2500 16.4500 18.8000 -56.05%
2015 34.7432 40.5100 44.5000 25.7800 42.7800 4.67%
2014 33.6709 28.9600 41.0700 27.8800 40.8700 39.97%
2013 33.0805 25.1700 40.4400 25.1700 29.2000 17.46%
2012 24.7038 24.4600 27.6200 21.6200 24.8600 4.28%
2011 25.0626 27.0000 33.0800 18.7100 23.8400 -12.55%
2010 31.5985 25.4500 39.7000 25.0500 27.2600 8.17%
2009 23.4653 20.4400 28.1900 16.7400 25.2000 22.87%
2008 23.4312 21.7400 34.7000 15.4000 20.5100 -6.60%
2007 19.6783 15.6100 25.5700 15.3500 21.9600 38.64%
2006 7.8764 6.7200 20.0900 2.2200 15.8400 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.047B $0.192B
Acorda Therapeutics, Inc. is a biotechnology company developing and commercializing neurology therapies for Parkinson's disease, migraine and multiple sclerosis. Acorda has a pipeline of novel neurological therapies addressing a range of disorders, including Parkinson's disease and multiple sclerosis. Acorda markets three FDA-approved therapies, including AMPYRA? (dalfampridine) Extended Release Tablets, 10 mg.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $122.963B 14.06
Gilead Sciences (GILD) United States $95.597B 12.37
CSL (CSLLY) Australia $87.858B 0.00
Vertex Pharmaceuticals (VRTX) United States $60.130B 54.57
Biogen (BIIB) United States $55.027B 9.40
Regeneron Pharmaceuticals (REGN) United States $52.039B 22.04
Illumina (ILMN) United States $40.606B 41.98
Seattle Genetics (SGEN) United States $19.860B 0.00
Alexion Pharmaceuticals (ALXN) United States $19.380B 8.99
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.120B 0.00
Incyte (INCY) United States $15.645B 33.57
BioMarin Pharmaceutical (BMRN) United States $14.842B 634.54
BioNTech SE (BNTX) Germany $14.028B 0.00
Genmab (GNMSF) Denmark $12.332B 39.66
Galapagos (GLPG) Belgium $12.312B 26.89
Alnylam Pharmaceuticals (ALNY) United States $12.306B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.513B 49.14
Moderna (MRNA) United States $10.028B 0.00
QIAGEN (QGEN) Netherlands $9.217B 28.10
Exact Sciences (EXAS) United States $8.646B 0.00
BeiGene (BGNE) Cayman Islands $8.167B 0.00
Sarepta Therapeutics (SRPT) United States $7.663B 0.00
Bio-Techne Corp (TECH) United States $7.317B 50.08
Guardant Health (GH) United States $6.725B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.419B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.581B 14.75
Ascendis Pharma (ASND) Denmark $5.538B 0.00
Exelixis (EXEL) United States $5.427B 17.42
Reata Pharmaceuticals (RETA) United States $5.379B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.069B 0.00
Repligen (RGEN) United States $4.991B 91.26
Amarin (AMRN) Ireland $4.851B 0.00
Acceleron Pharma (XLRN) United States $4.561B 0.00
China Biologic Products (CBPO) China $4.276B 25.38
Vir Biotechnology (VIR) United States $3.898B 0.00
Mirati Therapeutics (MRTX) United States $3.576B 0.00
Adaptive Biotechnologies (ADPT) United States $3.426B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.371B 0.00
MorphoSys AG (MOR) Germany $3.357B 0.00
Global Blood Therapeutics (GBT) United States $3.166B 0.00
Blueprint Medicines (BPMC) United States $3.132B 0.00
Zai Lab (ZLAB) China $3.078B 0.00
Immunomedics (IMMU) United States $2.944B 0.00
NeoGenomics (NEO) United States $2.905B 125.96
Emergent Biosolutions (EBS) United States $2.834B 19.67
CRISPR Therapeutics AG (CRSP) Switzerland $2.695B 45.66
Genmab (GMAB) Denmark $2.637B 10.34
Bluebird Bio (BLUE) United States $2.612B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.566B 0.00
Halozyme Therapeutics (HALO) United States $2.510B 0.00
Amicus Therapeutics (FOLD) United States $2.498B 0.00
MyoKardia (MYOK) United States $2.394B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.332B 0.00
Alkermes (ALKS) Ireland $2.272B 180.00
RA PHARMCTL INC (RARX) United States $2.241B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.136B 0.00
Arena Pharmaceuticals (ARNA) United States $2.116B 5.51
Denali Therapeutics (DNLI) United States $2.077B 0.00
UniQure (QURE) Netherlands $1.993B 0.00
Principia Biopharma (PRNB) United States $1.978B 0.00
Viela Bio (VIE) United States $1.938B 0.00
Alector (ALEC) United States $1.924B 0.00
Eidos Therapeutics (EIDX) United States $1.883B 0.00
Fate Therapeutics (FATE) United States $1.759B 0.00
Epizyme (EPZM) United States $1.666B 0.00
Zymeworks (ZYME) Canada $1.633B 0.00
Arvinas (ARVN) United States $1.606B 0.00
Insmed (INSM) United States $1.540B 0.00
Akcea Therapeutics (AKCA) United States $1.486B 31.96
Dicerna Pharmaceuticals (DRNA) United States $1.322B 0.00
REGENXBIO (RGNX) United States $1.253B 0.00
Coherus BioSciences (CHRS) United States $1.186B 14.11
Ligand Pharmaceuticals (LGND) United States $1.175B 36.52
Inovio Pharmaceuticals (INO) United States $1.169B 0.00
Twist Bioscience (TWST) United States $1.141B 0.00
Zealand Pharma (ZEAL) Denmark $1.120B 0.00
Editas Medicine (EDIT) United States $1.111B 0.00
Myriad Genetics (MYGN) United States $1.082B 19.09
NextCure (NXTC) United States $1.016B 0.00
PHARMA MAR SA (PHMMF) Spain $0.941B 0.00
NGM Biopharmaceuticals (NGM) United States $0.894B 0.00
Beam Therapeutics (BEAM) United States $0.894B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Intra-Cellular Therapies (ITCI) United States $0.876B 0.00
Adverum Biotechnologies (ADVM) United States $0.876B 0.00
Revance Therapeutics (RVNC) United States $0.875B 0.00
Cytokineticsorporated (CYTK) United States $0.760B 0.00
Sangamo Therapeutics (SGMO) United States $0.754B 0.00
Novavax (NVAX) United States $0.737B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.730B 0.00
Kadmon Holdings (KDMN) United States $0.706B 0.00
Athenex (ATNX) United States $0.664B 0.00
Frequency Therapeutics (FREQ) United States $0.650B 0.00
Codexis (CDXS) United States $0.642B 0.00
Pharming Group (PHGUF) Netherlands $0.632B 0.00
Intellia Therapeutics (NTLA) United States $0.620B 0.00
Cara Therapeutics (CARA) United States $0.620B 0.00
Retrophin (RTRX) United States $0.614B 0.00
Arcus Biosciences (RCUS) United States $0.612B 0.00
Bellus Health (BLU) Canada $0.606B 0.00
GENFIT S.A (GNFT) France $0.567B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.566B 0.00
Intrexon (PGEN) United States $0.553B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.543B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.533B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.519B 4.56
Compugen (CGEN) Israel $0.519B 0.00
Castle Biosciences (CSTL) United States $0.496B 0.00
AC Immune SA (ACIU) Switzerland $0.493B 12.59
ANI Pharmaceuticals (ANIP) United States $0.491B 8.85
Clovis Oncology (CLVS) United States $0.472B 0.00
Mesoblast (MESO) Australia $0.466B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
MeiraGTx Holdings (MGTX) United States $0.459B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.458B 0.00
Morphic Holding (MORF) United States $0.446B 0.00
DBV Technologies S.A (DBVT) France $0.445B 0.00
Heska (HSKA) United States $0.443B 0.00
Cel-Sci (CVM) United States $0.433B 0.00
Athersys (ATHX) United States $0.425B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.425B 0.00
Prothena (PRTA) Ireland $0.424B 0.00
Vericel (VCEL) United States $0.415B 61.60
Scholar Rock Holding (SRRK) United States $0.414B 0.00
Verastem (VSTM) United States $0.406B 0.00
Anika Therapeutics (ANIK) United States $0.404B 13.92
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.400B 0.00
MiMedx (MDXG) United States $0.397B 0.00
Agenus (AGEN) United States $0.388B 0.00
AnaptysBio (ANAB) United States $0.386B 0.00
Cellectis S.A (CLLS) France $0.384B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.383B 0.00
UROGEN PHARMA (URGN) United States $0.379B 0.00
Cue Biopharma (CUE) United States $0.365B 0.00
Merus (MRUS) Netherlands $0.364B 0.00
BioDelivery Sciences (BDSI) United States $0.359B 41.44
Adaptimmune Therapeutics (ADAP) United Kingdom $0.358B 0.00
PDL BioPharma (PDLI) United States $0.352B 10.56
Sorrento Therapeutics (SRNE) United States $0.335B 0.00
Puma Biotechnology (PBYI) United States $0.328B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.321B 0.00
WAVE Life Sciences (WVE) Singapore $0.318B 0.00
Precision BioSciences (DTIL) United States $0.318B 0.00
NantKwest (NK) United States $0.309B 0.00
Dynavax Technologies (DVAX) United States $0.307B 0.00
CytomX Therapeutics (CTMX) United States $0.305B 0.00
Pfenex (PFNX) United States $0.300B 439.00
Mersana Therapeutics (MRSN) United States $0.298B 0.00
Cellular Biomedicine (CBMG) United States $0.293B 0.00
Kala Pharmaceuticals (KALA) United States $0.289B 0.00
Avid Bioservices (CDMO) United States $0.278B 0.00
Seres Therapeutics (MCRB) United States $0.263B 0.00
Kamada (KMDA) Israel $0.256B 10.67
ADMA Biologics Inc (ADMA) United States $0.248B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.244B 0.00
Albireo Pharma (ALBO) United States $0.243B 0.00
Stemline Therapeutics (STML) United States $0.240B 0.00
Sutro Biopharma (STRO) United States $0.237B 0.00
Syros Pharmaceuticals (SYRS) United States $0.235B 0.00
Geron (GERN) United States $0.230B 0.00
MannKind (MNKD) United States $0.229B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.226B 0.00
Gritstone Oncology (GRTS) United States $0.212B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.211B 0.00
Selecta Biosciences (SELB) United States $0.205B 0.00
Aduro Biotech (ADRO) United States $0.204B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.201B 1.81
Alcobra (ARCT) United States $0.201B 0.00
XOMA (XOMA) United States $0.197B 0.00
Protagonist Therapeutics (PTGX) United States $0.196B 0.00
ChromaDex (CDXC) United States $0.188B 0.00
HOOKIPA Pharma (HOOK) United States $0.182B 0.00
OSMOTICA PHARM (OSMT) United States $0.176B 0.00
IVERIC Bio (ISEE) United States $0.174B 0.00
Abeona Therapeutics (ABEO) United States $0.171B 0.00
Starpharma Holdings (SPHRY) Australia $0.168B 0.00
VBI Vaccines (VBIV) United States $0.168B 0.00
Spero Therapeutics (SPRO) United States $0.163B 0.00
Biofrontera AG (BFRA) Germany $0.159B 0.00
Prometic Life Sciences (LMNL) Canada $0.156B 0.00
Kindred Biosciences (KIN) United States $0.154B 0.00
Aytu Bioscience (AYTU) United States $0.153B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.153B 0.00
POXEL SA FRANCE (PXXLF) France $0.145B 0.00
Liquidia Technologies (LQDA) United States $0.140B 0.00
Fortress Biotech (FBIO) United States $0.140B 0.00
Cerecor (CERC) United States $0.138B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.136B 0.00
Windtree Therapeutics (WINT) United States $0.136B 0.00
VolitionRX (VNRX) United States $0.134B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.132B 0.00
Dyadic (DYAI) United States $0.131B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.126B 0.00
Antibe Therapeutics (ATBPF) Canada $0.125B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.124B 4.88
VTv Therapeutics (VTVT) United States $0.123B 0.00
Affimed (AFMD) Germany $0.123B 0.00
Theratechnologies (THTX) Canada $0.121B 0.00
Exicure (XCUR) United States $0.119B 0.00
Enzo Biochem (ENZ) United States $0.119B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.114B 0.00
IBio (IBIO) United States $0.113B 0.00
Celyad SA (CYAD) Belgium $0.113B 0.00
AIT Therapeutics (XAIR) United States $0.108B 0.00
Palatin Technologies (PTN) United States $0.105B 2.88
Strongbridge Biopharma (SBBP) United States $0.103B 0.00
Aptinyx (APTX) United States $0.102B 0.00
Northwest Biotherapeutics (NWBO) United States $0.102B 0.00
PHASEBIO PHARMA (PHAS) United States $0.098B 0.00
Cidara Therapeutics (CDTX) United States $0.097B 0.00
OvaScience (MLND) United States $0.096B 0.00
CorMedix Inc (CRMD) United States $0.093B 0.00
TELA Bio (TELA) United States $0.092B 0.00
Five Prime Therapeutics (FPRX) United States $0.088B 0.00
Checkpoint Therapeutics (CKPT) United States $0.083B 0.00
ARAVIVE, INC (ARAV) United States $0.083B 0.00
Clearside Biomedical (CLSD) United States $0.079B 0.00
Arbutus Biopharma (ABUS) Canada $0.077B 0.00
Cyclerion Therapeutics (CYCN) United States $0.076B 0.00
Happiness Biotech Group (HAPP) China $0.074B 0.00
Pluristem Therapeutics (PSTI) Israel $0.074B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.073B 0.00
Eton Pharmaceuticals (ETON) United States $0.072B 0.00
Adocia (ADOCY) France $0.066B 0.00
Vaccinex (VCNX) United States $0.066B 0.00
Emmaus Life Sciences (EMMA) United States $0.065B 0.00
Menlo Therapeutics (MNLO) United States $0.064B 0.00
Proteostasis Therapeutics (PTI) United States $0.064B 0.00
SESEN BIO, INC (SESN) United States $0.061B 0.00
Orgenesis (ORGS) United States $0.061B 3.56
Applied Genetic Technologies (AGTC) United States $0.060B 0.00
Synlogic (SYBX) United States $0.059B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.057B 0.00
Trevena (TRVN) United States $0.057B 0.00
Catalyst Biosciences (CBIO) United States $0.054B 0.00
AquaBounty Technologies (AQB) United States $0.054B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.048B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.047B 0.00
Idera Pharmaceuticals (IDRA) United States $0.043B 0.00
Organovo Holdings (ONVO) United States $0.037B 0.00
Lumos Pharma (LUMO) United States $0.037B 0.00
AmpliPhi Biosciences (ARMP) United States $0.036B 0.00
Soligenix (SNGX) United States $0.036B 0.00
Protalix BioTherapeutics (PLX) Israel $0.035B 0.00
CollPlant Holdings (CLGN) Israel $0.034B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.034B 0.00
Cocrystal Pharma (COCP) United States $0.034B 0.00
Advaxis (ADXS) United States $0.033B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.032B 0.00
DiaMedica Therapeutics (DMAC) United States $0.031B 0.00
Prima BioMed (IMMP) Australia $0.030B 0.00
Celldex Therapeutics (CLDX) United States $0.029B 0.00
Evogene (EVGN) Israel $0.028B 0.00
TOCAGEN INC (TOCA) United States $0.028B 0.00
Celsion (CLSN) United States $0.025B 0.00
Curis (CRIS) United States $0.025B 0.00
Signal Genetics (MGEN) United States $0.025B 0.00
Entera Bio (ENTX) Israel $0.024B 0.00
BioCardia (BCDA) United States $0.023B 0.00
Pulmatrix (PULM) United States $0.023B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
VistaGen Therapeutics (VTGN) United States $0.022B 0.00
Novogen (KZIA) Australia $0.021B 0.00
Cleveland BioLabs (CBLI) United States $0.020B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.020B 0.00
Stellar Biotechnologies (EDSA) Canada $0.019B 0.00
Apricus Biosciences (SEEL) United States $0.018B 0.00
Oncobiologics (OTLK) United States $0.018B 0.00
Titan Pharmaceuticals (TTNP) United States $0.018B 0.00
Alimera Sciences (ALIM) United States $0.018B 0.00
Bionano Genomics (BNGO) United States $0.016B 0.00
Aptevo Therapeutics (APVO) United States $0.013B 0.00
Unum Therapeutics (UMRX) United States $0.013B 0.00
AEterna Zentaris (AEZS) United States $0.012B 0.00
ATyr Pharma (LIFE) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
TrovaGene (TROV) United States $0.011B 0.00
VIVUS (VVUS) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
Cesca Therapeutics (THMO) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
TRACON Pharmaceuticals (TCON) United States $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
IMMURON (IMRN) Australia $0.006B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Spherix (AIKI) United States $0.003B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00